NCT00159419View on ClinicalTrials.gov

Bisphosphonate Therapy for Osteogenesis Imperfecta

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Osteogenesis ImperfectaOsteoporosisPaget Disease of Bone
Interventions
DRUG

Alendronate

DRUG

Pamidronate

All Listed Sponsors
lead

Indiana University School of Medicine

OTHER

NCT00159419 - Bisphosphonate Therapy for Osteogenesis Imperfecta | Biotech Hunter | Biotech Hunter